ABC News
For the first time, women in the United States have the ability to self-collect a sample to screen for human papillomavirus (HPV). This week, the U.S. Food and Drug Administration approved two self-swab tests from pharmaceutical companies Becton, Dickinson and Company (BD) and Roche Holding AG for "clinical" use, meaning in a private room inside a doctor's office, mobile clinic or another health care setting. HPV is the most common sexually transmitted infection in the U.S. and can lead to several potentially deadly cancers, including cervical cancer.